Comerica Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-698
Closed -$1.03K 3749
2025
Q1
$1.03K Sell
698
-121,385
-99% -$289K ﹤0.01% 3559
2024
Q4
$541K Sell
122,083
-28,108
-19% -$114K ﹤0.01% 1837
2024
Q3
$619K Buy
150,191
+106,892
+247% +$575K ﹤0.01% 1783
2024
Q2
$282K Sell
43,299
-6,160
-12% -$43.6K ﹤0.01% 2113
2024
Q1
$431K Sell
49,459
-5,945
-11% -$72.1K ﹤0.01% 1944
2023
Q4
$634K Sell
55,404
-89
-0.2% -$880 ﹤0.01% 1761
2023
Q3
$534K Buy
+55,493
New +$544K ﹤0.01% 1760
2022
Q4
$846K Sell
74,140
-23,987
-24% -$272K 0.01% 1545
2022
Q3
$1.03M Sell
98,127
-27,845
-22% -$316K 0.01% 1446
2022
Q2
$1.48M Sell
125,972
-481,275
-79% -$5.67M 0.01% 1295
2022
Q1
$7.3M Buy
607,247
+4,290
+0.7% +$49.2K 0.05% 408
2021
Q4
$6.72M Buy
602,957
+103,370
+21% +$1.27M 0.05% 429
2021
Q3
$6.51M Sell
499,587
-20,110
-4% -$260K 0.04% 538
2021
Q2
$6.76M Buy
519,697
+230,720
+80% +$2.64M 0.04% 537
2021
Q1
$3.21M Buy
288,977
+86,111
+42% +$910K 0.02% 1051
2020
Q4
$2.1M Buy
202,866
+135,670
+202% +$1.48M 0.01% 1276
2020
Q3
$648K Buy
67,196
+15,873
+31% +$158K ﹤0.01% 1794
2020
Q2
$508K Sell
51,323
-7,599
-13% -$77.8K ﹤0.01% 1861
2020
Q1
$606K Buy
+58,922
New +$693K 0.01% 1638

Other funds holding IRWD

Comerica Bank's IRWD Position: Q2 2025 in Review

Comerica Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 698 shares — an estimated $1.03K sold.

Comerica Bank first reported a position in IRWD in Q1 2020 and held it in 19 quarters. The position peaked at $7.3M in Q1 2022. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Comerica Bank reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Comerica Bank sold 698 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $1.03K.
  • Comerica Bank first reported a position in Ironwood Pharmaceuticals in Q1 2020 and held it in 19 quarters.
  • Comerica Bank's Ironwood Pharmaceuticals position peaked at $7.3M in Q1 2022.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.